Eintrag weiter verarbeiten

Optimization of rituximab for the treatment of diffuse large B-Cell lymphoma (II): extended rituximab exposure time in the SMARTE-R-CHOP-14 trial of the German High-Grade Non-Hodgk...

Gespeichert in:

Veröffentlicht in: Journal of clinical oncology 32(2014), 36, Seite 4127-4133
Personen und Körperschaften: Pfreundschuh, Michael (Sonstige), Witzens-Harig, Mathias (Sonstige)
Titel: Optimization of rituximab for the treatment of diffuse large B-Cell lymphoma (II): extended rituximab exposure time in the SMARTE-R-CHOP-14 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group/ Pfreundschuh M., Poeschel V., Zeynalova S., Hänel M., Held G., Schmitz N., Viardot A., Dreyling M.H., Hallek M., Mueller C., Wiesen M.H., Witzens-Harig M., Truemper L., Keller U., Rixecker T., Zwick C., Murawski N.
Format: E-Book-Kapitel
Sprache: Englisch
veröffentlicht:
2014
Gesamtaufnahme: : Journal of clinical oncology, 32(2014), 36, Seite 4127-4133
, volume:32
Quelle: Verbunddaten SWB
Lizenzfreie Online-Ressourcen
LEADER 02217caa a2200493 4500
001 0-1504042328
003 DE-627
005 20220812004246.0
007 cr uuu---uuuuu
008 150619s2014 xx |||||o 00| ||eng c
024 7 |a 10.1200/JCO.2013.54.6861  |2 doi 
035 |a (DE-627)1504042328 
035 |a (DE-576)434042323 
035 |a (DE-599)BSZ434042323 
035 |a (OCoLC)1340692110 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
245 1 0 |a Optimization of rituximab for the treatment of diffuse large B-Cell lymphoma (II)  |b extended rituximab exposure time in the SMARTE-R-CHOP-14 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group  |c Pfreundschuh M., Poeschel V., Zeynalova S., Hänel M., Held G., Schmitz N., Viardot A., Dreyling M.H., Hallek M., Mueller C., Wiesen M.H., Witzens-Harig M., Truemper L., Keller U., Rixecker T., Zwick C., Murawski N. 
264 1 |c 2014 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 19.06.2015 
700 1 |a Pfreundschuh, Michael  |d 1949-2018  |0 (DE-588)108615871  |0 (DE-627)394701879  |0 (DE-576)289617227  |4 oth 
700 1 |a Witzens-Harig, Mathias  |0 (DE-588)1050736516  |0 (DE-627)784812322  |0 (DE-576)404988970  |4 oth 
773 0 8 |i In  |t Journal of clinical oncology  |d Alexandria, Va. : American Society of Clinical Oncology, 1983  |g 32(2014), 36, Seite 4127-4133  |h Online-Ressource  |w (DE-627)313116962  |w (DE-600)2005181-5  |w (DE-576)090887018  |x 1527-7755  |7 nnns 
773 1 8 |g volume:32  |g year:2014  |g number:36  |g pages:4127-4133  |g extent:7 
856 4 0 |u http://dx.doi.org/10.1200/JCO.2013.54.6861  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
936 u w |d 32  |j 2014  |e 36  |h 4127-4133  |g 7 
951 |a AR 
856 4 0 |u http://dx.doi.org/10.1200/JCO.2013.54.6861  |9 LFER 
852 |a LFER  |z 2015-07-13T00:00:00Z 
970 |c OD 
971 |c EBOOK 
972 |c EBOOK 
973 |c Aufsatz 
935 |a lfer 
900 |a Witzens-Harig, M. 
900 |a Harig, Mathias Witzens- 
900 |a Harig, M. Witzens- 
900 |a Witzens-Harig, Matthias 
900 |a Witzens, M. 
980 |a 1504042328  |b 0  |k 1504042328  |o 434042323  |c lfer 
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Optimization+of+rituximab+for+the+treatment+of+diffuse+large+B-Cell+lymphoma+%28II%29%3A+extended+rituximab+exposure+time+in+the+SMARTE-R-CHOP-14+trial+of+the+German+High-Grade+Non-Hodgkin+Lymphoma+Study+Group&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Adc&rft.creator=&rft.pub=&rft.format=Journal&rft.language=English&rft.issn=1527-7755
SOLR
_version_ 1757940074576609280
access_facet Electronic Resources
author2 Pfreundschuh, Michael, Witzens-Harig, Mathias
author2_role oth, oth
author2_variant m p mp, m w h mwh
author_facet Pfreundschuh, Michael, Witzens-Harig, Mathias
callnumber-sort
collection lfer
container_reference 32(2014), 36, Seite 4127-4133
container_title Journal of clinical oncology
ctrlnum (DE-627)1504042328, (DE-576)434042323, (DE-599)BSZ434042323, (OCoLC)1340692110
doi_str_mv 10.1200/JCO.2013.54.6861
facet_avail Online, Free
finc_class_facet not assigned
finc_id_str 0017792720
footnote Gesehen am 19.06.2015
format ElectronicBookComponentPart
format_access_txtF_mv Article, E-Article
format_de105 Ebook
format_de14 Article, E-Article
format_de15 Article, E-Article
format_del152 Buch
format_detail_txtF_mv text-online-monograph-child
format_dezi4 e-Book
format_finc Article, E-Article
format_legacy ElectronicBookPart
format_strict_txtF_mv E-Article
geogr_code not assigned
geogr_code_person not assigned
hierarchy_parent_id 0-313116962
hierarchy_parent_title Journal of clinical oncology
hierarchy_sequence 32(2014), 36, Seite 4127-4133
hierarchy_top_id 0-313116962
hierarchy_top_title Journal of clinical oncology
id 0-1504042328
illustrated Not Illustrated
imprint 2014
imprint_str_mv 2014
institution DE-D117, DE-105, LFER, DE-Ch1, DE-15, DE-14, DE-Zwi2
is_hierarchy_id 0-1504042328
is_hierarchy_title Optimization of rituximab for the treatment of diffuse large B-Cell lymphoma (II): extended rituximab exposure time in the SMARTE-R-CHOP-14 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group
isil_str_mv LFER
issn 1527-7755
kxp_id_str 1504042328
language English
last_indexed 2023-02-15T23:04:57.828Z
marc024a_ct_mv 10.1200/JCO.2013.54.6861
match_str pfreundschuh2014optimizationofrituximabforthetreatmentofdiffuselargebcelllymphomaiiextendedrituximabexposuretimeinthesmarterchop14trialofthegermanhighgradenonhodgkinlymphomastudygroup
mega_collection Verbunddaten SWB, Lizenzfreie Online-Ressourcen
misc_de105 EBOOK
multipart_link 090887018
multipart_part (090887018)32(2014), 36, Seite 4127-4133
names_id_str_mv (DE-588)108615871, (DE-627)394701879, (DE-576)289617227, (DE-588)1050736516, (DE-627)784812322, (DE-576)404988970
oclc_num 1340692110
physical 7
publishDate 2014
publishDateSort 2014
publishPlace
publisher
record_format marcfinc
record_id 434042323
recordtype marcfinc
rvk_facet No subject assigned
source_id 0
spelling Optimization of rituximab for the treatment of diffuse large B-Cell lymphoma (II) extended rituximab exposure time in the SMARTE-R-CHOP-14 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group Pfreundschuh M., Poeschel V., Zeynalova S., Hänel M., Held G., Schmitz N., Viardot A., Dreyling M.H., Hallek M., Mueller C., Wiesen M.H., Witzens-Harig M., Truemper L., Keller U., Rixecker T., Zwick C., Murawski N., 2014, 7, Text txt rdacontent, Computermedien c rdamedia, Online-Ressource cr rdacarrier, Gesehen am 19.06.2015, Pfreundschuh, Michael 1949-2018 (DE-588)108615871 (DE-627)394701879 (DE-576)289617227 oth, Witzens-Harig, Mathias (DE-588)1050736516 (DE-627)784812322 (DE-576)404988970 oth, In Journal of clinical oncology Alexandria, Va. : American Society of Clinical Oncology, 1983 32(2014), 36, Seite 4127-4133 Online-Ressource (DE-627)313116962 (DE-600)2005181-5 (DE-576)090887018 1527-7755 nnns, volume:32 year:2014 number:36 pages:4127-4133 extent:7, http://dx.doi.org/10.1200/JCO.2013.54.6861 Verlag Resolving-System kostenfrei Volltext, http://dx.doi.org/10.1200/JCO.2013.54.6861 LFER, LFER 2015-07-13T00:00:00Z
spellingShingle Optimization of rituximab for the treatment of diffuse large B-Cell lymphoma (II): extended rituximab exposure time in the SMARTE-R-CHOP-14 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group
swb_id_str 434042323
title Optimization of rituximab for the treatment of diffuse large B-Cell lymphoma (II): extended rituximab exposure time in the SMARTE-R-CHOP-14 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group
title_auth Optimization of rituximab for the treatment of diffuse large B-Cell lymphoma (II) extended rituximab exposure time in the SMARTE-R-CHOP-14 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group
title_full Optimization of rituximab for the treatment of diffuse large B-Cell lymphoma (II) extended rituximab exposure time in the SMARTE-R-CHOP-14 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group Pfreundschuh M., Poeschel V., Zeynalova S., Hänel M., Held G., Schmitz N., Viardot A., Dreyling M.H., Hallek M., Mueller C., Wiesen M.H., Witzens-Harig M., Truemper L., Keller U., Rixecker T., Zwick C., Murawski N.
title_fullStr Optimization of rituximab for the treatment of diffuse large B-Cell lymphoma (II) extended rituximab exposure time in the SMARTE-R-CHOP-14 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group Pfreundschuh M., Poeschel V., Zeynalova S., Hänel M., Held G., Schmitz N., Viardot A., Dreyling M.H., Hallek M., Mueller C., Wiesen M.H., Witzens-Harig M., Truemper L., Keller U., Rixecker T., Zwick C., Murawski N.
title_full_unstemmed Optimization of rituximab for the treatment of diffuse large B-Cell lymphoma (II) extended rituximab exposure time in the SMARTE-R-CHOP-14 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group Pfreundschuh M., Poeschel V., Zeynalova S., Hänel M., Held G., Schmitz N., Viardot A., Dreyling M.H., Hallek M., Mueller C., Wiesen M.H., Witzens-Harig M., Truemper L., Keller U., Rixecker T., Zwick C., Murawski N.
title_in_hierarchy Optimization of rituximab for the treatment of diffuse large B-Cell lymphoma (II): extended rituximab exposure time in the SMARTE-R-CHOP-14 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group / Pfreundschuh M., Poeschel V., Zeynalova S., Hänel M., Held G., Schmitz N., Viardot A., Dreyling M.H., Hallek M., Mueller C., Wiesen M.H., Witzens-Harig M., Truemper L., Keller U., Rixecker T., Zwick C., Murawski N.,
title_short Optimization of rituximab for the treatment of diffuse large B-Cell lymphoma (II)
title_sort optimization of rituximab for the treatment of diffuse large b cell lymphoma ii extended rituximab exposure time in the smarte r chop 14 trial of the german high grade non hodgkin lymphoma study group
title_sub extended rituximab exposure time in the SMARTE-R-CHOP-14 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group
url http://dx.doi.org/10.1200/JCO.2013.54.6861